BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $355.40M in the twelve months ending March 31, 2024, with 22.68% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $92.76M with 34.87% year-over-year growth. In the year 2023, BioCryst Pharmaceuticals had annual revenue of $331.41M with 22.37% growth.

• Revenue (ttm): $355.40M
• Revenue Growth: +22.68%
• P/S Ratio: 4.15
• Revenue / Employee: $663,050
• Employees: 536
• Market Cap: 1.47B USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	331.41M	60.59M	22.37%
Dec 31, 2022	270.83M	113.66M	72.31%
Dec 31, 2021	157.17M	139.36M	782.38%
Dec 31, 2020	17.81M	-31.02M	-63.53%
Dec 31, 2019	48.84M	28.18M	136.45%
Dec 31, 2018	20.65M	-4.53M	-18.00%
Dec 31, 2017	25.19M	-1.17M	-4.43%
Dec 31, 2016	26.35M	-21.90M	-45.39%
Dec 31, 2015	48.26M	34.65M	254.62%
Dec 31, 2014	13.61M	-3.72M	-21.48%
Dec 31, 2013	17.33M	-8.96M	-34.09%
Dec 31, 2012	26.29M	6.65M	33.85%
Dec 31, 2011	19.64M	-42.74M	-68.51%
Dec 31, 2010	62.38M	-12.21M	-16.37%
Dec 31, 2009	74.59M	18.03M	31.87%
Dec 31, 2008	56.56M	-14.68M	-20.60%
Dec 31, 2007	71.24M	65.03M	1,046.79%
Dec 31, 2006	6.21M	6.06M	3,990.38%
Dec 31, 2005	151.87K	-185.03K	-54.92%
Dec 31, 2004	336.90K	-316.35K	-48.43%
Dec 31, 2003	653.26K	-	-
Dec 31, 2002	0	-	-
Dec 31, 2001	11.16M	3.50M	45.64%
Dec 31, 2000	7.66M	2.33M	43.77%
Dec 31, 1999	5.33M	-2.30M	-30.12%
Dec 31, 1998	7.63M	4.93M	183.23%
Dec 31, 1997	2.69M	40.36K	1.52%
Dec 31, 1996	2.65M	1.77M	199.82%
Dec 31, 1995	884.59K	150.77K	20.55%
Dec 31, 1994	733.82K	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.